Aligos Therapeutics, Inc.ALGSNASDAQ
LOADING
|||
| Metric | Dec 20 | Dec 21 | Dec 22 | Dec 23 | Dec 24 |
|---|---|---|---|---|---|
| Revenue | 0 | 4 | 14↑219.0% | 16↑11.7% | 4↓74.6% |
| Gross Profit | -3 | 4↑231.1% | 14↑219.0% | 16↑11.7% | 4↓74.6% |
| Operating Income | -98 | -128↓31.2% | -98↑24.0% | -88↑9.7% | -89↓1.2% |
| Net Income | -109 | -128↓18.2% | -96↑25.2% | -88↑8.7% | -131↓49.6% |
| EBITDA | -105 | -125↓18.5% | -94↑24.6% | -85↑9.4% | -87↓1.7% |
| EPS Diluted | -3.18 | -3.22↓1.3% | -2.25↑30.1% | -3.52↓56.4% | -20.94↓494.9% |